ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166641 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166641; 2) Community: the network communities that were significantly associated with the response to NSC 166641; 3) Molecule: the relationships between components within communities and NSC 166641; 4) MDR: the compounds that were significantly associated with the NSC 166641.

NSC Compound Enrichment Correlation
NSC 726767 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate 0.000272379738694984 0.38108495
NSC 150014 Hydrazine dihydrogen sulfate salt 0.000345299270690661 0.61075412
NSC 683416 1H-Pyrrole-2-carboxamide, N-[2-[[[4-[[5,5a,6,8,8a,9-hexahydro- 5-(4-hydroxy-3,5-dimethoxyphenyl)- 6-oxofuro[3',4':6,7]naphtho[1,2-d]-1,3-dioxol-9-yl]amino] phenyl]amino]carbonyl]-1-methyl-1H-pyrrol-4 0.000345299270690661 0.55035343
NSC 740 Methotrexate 0.00036608087748593 0.41848467
NSC 102627 Yoshi 864 0.000429167759775562 0.60375356
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.000429167759775562 0.53003341
NSC 677169 Null 0.000429167759775562 0.5517439
NSC 680420 Null 0.000429167759775562 0.3612603
NSC 681644 Camptothecin Derivative 0.000429167759775562 0.48695115
NSC 697685 Null 0.000429167759775562 0.51862587
Total:106  Current:3    [First] [Prev] [Next] [Last]